When chemotherapy was first invented, its premise seemed relatively simple: to curb the growth of tumors by stopping their cells from proliferating. Today, many of these drugs are known to act through different mechanisms, ...
Oct 15, 2019
0
95
Cancer cells become addicted to glucose, which they use as their regular source of energy to grow and develop. Although this was observed over nine decades ago by the German physiologist, Otto Warburg; there is still not ...
Aug 31, 2015
0
25
(Medical Xpress)—Taxol, generically called paclitaxel, is a widely used drug in chemotherapy treatments. Taxol is used to treat cancer in the lungs, ovaries and breast, but it can also cause severe neuropathic pain and ...
Oct 30, 2013
0
0
In a study to be published today in Scientific Reports, researchers from the Florida International University Herbert Wertheim College of Medicine and the FIU College of Engineering and Computing describe what could be a ...
Oct 17, 2013
0
0
Working with cells in test tubes and in mice, researchers at Johns Hopkins have discovered that a chemical commonly used as a dog food preservative may prevent the kind of painful nerve damage found in the hands and feet ...
Sep 20, 2013
0
0
One major hallmark of cancer cells is their ability to survive under stressful conditions. A new study spearheaded by researchers at Sanford-Burnham Medical Research Institute reveals how a promising anticancer compound called ...
Jul 30, 2013
0
0
By tracking changes in patients' blood, Cambridge scientists have created a new way of looking at how tumours evolve in real-time and develop drug resistance. The research was published in the print edition of Nature today.
May 3, 2013
0
0
(HealthDay)—Margaret Zuccotti was nursing her third child in August of 2006 when she noticed that her breast was red, swollen and tender to the touch. Because she'd had other children, she chalked up her symptoms to a simple ...
Oct 5, 2012
0
0
(HealthDay) -- Even in the field of cancer treatment, sometimes newer isn't necessarily better.
Jun 4, 2012
0
0
(Medical Xpress) -- Blocking key proteins could improve response to a common chemotherapy drug, suggests an Oxford University-led study which used cancer cells grown in the lab.
Sep 2, 2011
0
0
